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background:  We sought to characterize the cost variation of catheter ablation for atrial fibrillation (AF) in the United States health care 
system and the relationship between cost and outcomes.
Methods:  We analyzed data from MarketScan® Commercial Claims and Medicare Supplemental database (Truven Health Analytics, 
Ann Arbor, MI), which contains fully adjudicated data on 45 million patients covered under a variety of fee-for-service and managed care 
health plans. We identified ablation procedures for AF from 2006 to 2011 using a previously validated algorithm. Cost was obtained by 
summing all encounter payments and aggregated to the site where the procedure was performed. We excluded patients without one year 
of enrollment post-ablation, ablations with costs < $1,000, and sites with < 10 total ablations. Site level costs were reported as medians and 
25th-75th interquartile range due to non-normal distributions and outcomes were compared across quintiles based on cost.
results:  In 10,992 AF ablations (29.2% outpatient; 71.8% inpatient; age 59.5±10.9 years; 30.5% female) occurring in 392 sites, there was 
large cost variation ($20,600; IQR $16,200-$28,300). Five percent of sites had a median cost ≥ $48,200, and one percent had a median 
cost ≥ $77,300. Among the least and most expensive quintiles, the one-year rate of hospitalization for AF was 19.1% and 16.0% (p <0.001 
for trend) while the one-year rate of repeat ablation was 16.1% and 13.4% (p <0.030 for trend), respectively. The 30-day rate of perforation/
tamponade was 3.8% and 7.9% in the least and most expensive quintiles respectively (p <0.0001 for trend). Unadjusted median costs 
increased by 27% from 2006 to 2011 and was higher in all years than cost inputs used in published cost-effectiveness analyses.
Conclusion:  We found wide site-level variation in cost of AF ablation. With increasing strata of cost, there was a small gradient in 
improvement of outcomes but also an increase in safety events, both of which may be drivers of cost. These findings may challenge the 
assumptions of cost-effectiveness of AF ablation and may have implications for planned bundling of payments and readmission payment 
penalties planned for AF under the Affordable Care Act.
